Nutriband Inc. (NTRB)
NASDAQ: NTRB · Real-Time Price · USD
4.260
+0.065 (1.55%)
At close: Feb 20, 2026, 4:00 PM EST
4.450
+0.190 (4.46%)
After-hours: Feb 20, 2026, 7:39 PM EST
Revenue by Segment
Financials in millions USD. Fiscal year is February - January.
Millions USD. Fiscal year is Feb - Jan.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 | Jan '21 Jan 31, 2021 | Jan '20 Jan 31, 2020 | Jan '19 Jan 31, 2019 | Jan '18 Jan 31, 2018 | Jan '17 Jan 31, 2017 | Jan '16 Jan 31, 2016 |
|---|
| 2.14M | 1.92M | 1.79M | 1.18M | 737.52K | | | | | |
Pocono Pharmaceuticals Growth | 11.42% | 7.54% | 51.37% | 59.94% | - | | | | | |
| - | 165.03K | 294.10K | 242.53K | 206.18K | | | | | |
| - | -43.89% | 21.26% | 17.63% | - | | | | | |
| 2.14M | 2.09M | 2.08M | 1.42M | 943.70K | | | | | |
| 2.60% | 0.27% | 46.24% | 50.70% | 154.61% | | | | | |
Revenue by Geography
Financials in millions USD. Fiscal year is February - January.
Millions USD. Fiscal year is Feb - Jan.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 | Jan '21 Jan 31, 2021 | Jan '20 Jan 31, 2020 | Jan '19 Jan 31, 2019 | Jan '18 Jan 31, 2018 | Jan '17 Jan 31, 2017 | Jan '16 Jan 31, 2016 |
|---|
| 2.14M | 2.09M | 2.08M | 1.34M | 360.38K | | | | | |
| 2.60% | 0.27% | 55.72% | 270.60% | 46.69% | | | | | |
Outside the United States | - | - | - | 86.60K | 583.32K | | | | | |
Outside the United States Growth | - | - | - | -85.15% | 366.82% | | | | | |
| 2.14M | 2.09M | 2.08M | 1.42M | 943.70K | | | | | |
| 2.60% | 0.27% | 46.24% | 50.70% | 154.62% | | | | | |
Source: S&P Global Market Intelligence.